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Introduction
Nowadays, cancer is a major health problem in 
many countries (Keyghobadi et al., 2015; Razi et al., 
2015; Zahedi et al., 2015; Zeinalzadeh et al., 2015). 
Currently cancer is the second leading cause of death in 
economically developed countries and the third leading 
cause of death in developing countries (Garcia et al., 
2007; Almasi et al., 2015). Breast cancer (BC) is the 
most common cancer (27% of all cancers) and is the 
main cause of death (16%) due to cancer in women in 
developed countries and in developing ones (Ghoncheh et 
al., 2015; Payandeh et al., 2015a). It is also the main cause 
of oncology death in women in these countries (Jemal 
et al., 2011). BC comprises about one-fifth of all female 
cancers. This cancer is the cause of deaths in high-income 
countries and the second cause of death in low and 
middle income countries (Payandeh et al., 2015b). BC is 
the most common cause of death in middle-aged women 
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in developed and developing countries and its prevalence 
is rapidly increasing. 
According to Fuladi et al study (2011) in recent years, 
the mortality rate of BC has increased rapidly in all 
countries. In Iran, every year 40,000 people lose their lives 
due to cancer and more than 70,000 new cases of cancer 
happens. BC is the most common malignancy among 
Iranian women (Mousavi et al., 2007). The average age of 
BC diagnosis in Iran is about 46 to 49 years (Ahmadi et al., 
2015). BC has the first rank among diagnosed cancers in 
Iranian women. The overall mortality rate of BC during the 
ears 1990, 1995, 2000, 2005 and 2010 has increased from 
0.96 to 4.33 per 100,000 people and also the incidence rate 
increased from 16.0 to 28.3 per 100,000 people during the 
study year (Sharifian et al., 2015). Female diseases and 
BC include 7.8% and 25.6% of all cancers in women in 
Iran, respectively, and these values are lower compared 
to other countries (Arab et al., 2013). Although Iran, with 
the incidence rate of 24 cases per 100,000 people, has one 
1Health Promotion Research Center, Department of Epidemiology and Biostatistics, School of Public Health, Zahedan University of Medical 
Sciences, Zahedan, 2Students’ Scientific Research Center, 3Department of Epidemiology and Biostatistics, School of Public Health, Tehran 
University of Medical Sciences, 8Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, 4Department of 
Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan,5Clinical Microbiology Research 
Center, 6Department of Microbiology, Medical School, Ilam University of Medical Sciences, Ilam, 7Birjand University of Medical Sciences, Birjand, 
Iran.*For correspondence: alesaleh70@yahoo.com 
Neda Mahdavifar et al
Asian Pacific Journal of Cancer Prevention, Vol 17, Cancer Control in Western Asia Special Issue, 201660
of the lowest rates of BC in the world, this disease is the 
most common cancer among Iranian women and due to 
the changes in risk factors and demographic pattern. BC 
is expected to increase sharply over the coming decades 
in this country (Sadjadi et al., 2009). 
In Iran, BC with the frequency of 23% of women 
cancers is the most common form of cancer of this sex and 
overall, 0.9 percent of all deaths in age category of 15-49 
years and 0.9 percent of all deaths in age group of 50-69 
years in the country are due to BC in 2009 (Khosravi et 
al., 2013; Keyghobadi et al., 2015). Looking at the peak 
age of this cancer in Iranian women which is reported in 
fourth and fifth life decades reveals that it is lower than 
the global statistic as much as a decade (Health). Thus, 
after age adjusting, Iranian patients are younger and are 
in advanced stage of disease compared with their western 
counterparts as much as at least one decade (Afsharfard 
et al., 2013).
Despite the high prevalence of BC in Iranian women, 
the epidemiological characteristics of BC in Iranian 
patients is yet unknown (Ahmadi et al., 2015). Due to 
the upward trend of this cancer mortality (Taghavi et al., 
2012) and based on similar patterns, it is expected that 
the mortality rate in Iranian women population  generally 
increase (Haghighat et al., 2012). 
Senility is considered as one of the main risk factors for 
this cancer. BC begins as a local disease but it can lead to 
lymph nodes and distant organs metastasis (Weigelt et al., 
2005). Blood group, BMI, menarche age and high blood 
pressure are not the risk factors for BC alone, but probably 
a combination of these factors can increase the risk of BC 
incidence (Payandeh et al., 2015b). Known risk factors for 
BC include: age, family history, genetics, personal history 
of BC, chest or face radiation before age 30, ethnicity, 
race, overweightness, pregnancy, breastfeeding and 
menstrual history, Hormone Replacement Therapy use 
(HRT), drinking alcohol, having dense breasts, lack of 
exercise, and smoking (Majeed et al., 2014). 
Differences in culture, habits and ethnicity in many 
countries of the Eastern Mediterranean Region (such as 
Iran, Tunisia and Pakistan) show that the BC diagnosis 
age is younger than the rest of the world (Bidgoli and 
Azarshab, 2013). Also, some countries in the Eastern 
Mediterranean Region, due to lack of knowledge about 
BC screening than other regions, are in more advanced 
stages of cancer at diagnosis time (Harirchi et al., 2011). 
The BC treatment varies according to the grade and 
stage of cancer and the patients’ physical condition and 
demand (Yaghmaei et al., 2008). Early detection of BC 
plays a major role in reducing mortality and improving 
patients’ prognosis among women (Elmore et al., 2005; 
Hoerger et al., 2011). So in some cancers, such as BC, 
long-term survival is expected to occur (Rahimzadeh et 
al., 2013). 
Paying attention to the cancer as a health priority 
at  national and regional levels is  among the 
requirements  of  the health system. So due to the changing life 
patterns, proportional control of communicable diseases 
and increased life expectancy in Iran, it is expected that 
incidence of cancer will increase in the coming years. 
Therefore, it is necessary to examine the epidemiological 
situation of cancer in different regions of the country. So 
this study was done with the aim of the spatial analysis 
of BC incidence in Iran.
Materials and Methods 
The study area
Iran is a country in the Middle-East with the area of 
1,648,195 square-kilometers, is the 18th largest country in 
the world and has a population of over 75 million (2011). 
Iran has a variety of environmental conditions in terms of 
length and breadth of geography, topographic diversity, 
and a range of altitude up to 5,671 meters above sea level. 
The Iranian climate varies from arid to subtropical. Iran 
is bordered by Armenia, Turkmenistan, and Azerbaijan to 
the north, (as well as by Russia and Kazakhstan via a water 
border in the Caspian Sea); Afghanistan and Pakistan in 
the east; the Persian Gulf and Gulf of Oman to the south; 
Iraq to the east; and Turkey to the northwest (Mostafavi 
Table1. Standardized Incidence Rates of Breast 
Cancer in Iranian Provinces 
NO Province BC  Incidence 
1 Ardebil 13.4
2 Isfahan 39.7
3 Ilam 13.8
4 Azerbaijan-Shargi 28.9
5 Azerbaijan-Gharbi 16.4
6 Bushehr 25.6
7 Tehran 43.4
8 Chaharmahal 20.2
9 Khorasan-Jonobi 11.5
10 Khorasan-Markazi 23.5
11 Khorasan-Shomali 11.4
12 Khozestan 32.0
13 Zanjan 11.6
14 Semnan 28.1
15 Sistan 5.4
16 Fars 36.2
17 Ghazvin 18.4
18 Qom 13.1
19 Kordestan 19.0
20 Kerman 23.0
21 Kermanshah 25.1
22 Kohgiloye 15.1
23 Golestan 17.7
24 Guilan 27.7
25 Lorestan 19.2
26 Mazandaran 28.0
27 Markazi 36.6
28 Hormozgan 11.9
29 Hamedan 23.3
30 Yazd 38.5
31 Total 33.2
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et al., 2013). Iran is currently divided into 31 provinces.
Study design and data collection
This is an ecological study in Iran. The data were 
collected from Cancer Registry Center report of health 
deputy which is based on Iran ministry of health 
guideline (Goya,  2007).  Data were collected 
retrospectively reviewing all new BC patients in 
cancer registry center report of health deputy for Iran in 
2009. BC was defined as ICD-OC16. Age-standardized 
rates of cancer incidence were calculated by the 
direct standardization method, using the world standard 
population as a reference (Rahimi and Heidari, 2012). 
After data collection, information was inserted into 
Excel datasheets. Using Excel was justified by the 
faster computational capabilities and the ability to 
convert and store data in tables which can be linked 
to geographical maps in ArcGIS software, as well as 
it being an interactive environment for checking numbers 
simultaneously when entering data. 
Spatial analysis by GIS
The most recent updated electronic map of Iran and 
its provinces was used. To link data tables to the map, a 
so-called ID field was created in the Excel tables reporting 
the incidence of BC. The code entered corresponded to 
the code of a province in the map data tables. The tables 
and map were then linked by a common field.
Identifying disease Hot-Spots was done using 
Getis-Ord Gi* (Spatial Statistics) (Figure 1). An 
Hot-Spot was defined as a province which not only 
has a high incidence of disease itself but also has a 
neighboring  province  with  a  high incidence.  In other words, the 
Hot-Spots Analysis shows that provinces with high 
incidence of disease become a focus of disease if there is 
high incidence in surrounding provinces as well. To the 
contrary, it can be said that ‘Cold-Spots’ are provinces 
with not only low incidence but also with low-incidence 
neighbors. Provinces that were 1.96 SD higher or lower 
than the national average considered as Hot Spots or Cold 
Spots at the level of 0.05%.
Results 
In 2009, a total of 7,582 cases of BC occurred in 
Iran. The annual incidence of BC was 33.2 per hundred 
thousand people. Our study showed that the highest 
Incidence of BC in women was for the central provinces 
of the country,  the Provinces of Tehran with 43.4, Isfahan 
with 39.7, Yazd with 38.5, Markazi with 36.6 and Fars 
with 36.2 per hundred thousand people have shown the 
highest rate of incidence, respectively (Table 1).
The results of Hot Spots analysis showed that the 
distribution of high-risk BC areas is more in central 
provinces of the country,  the Isfahan province was known 
as a Hot Spot for BC (p<0.01). The other provinces were 
not significantly different from the national average 
(Figure 2).
Figure 2: Hot Spots of Breast Cancer in Females in 2009
Figure 1. Getis-Ord Gi* (Spatial Statistics) - where 
Xi is the Attribute Value for Feature j, wij is the 
Spatial Weight between Feature i and j, n is Equal to the 
Total Number of Features.
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Discussion
Iran, in the western part of Asia, faces an increased 
incidence of BC (Mousavi et al., 2006). According to 
new statistics in Iran, each year 6160 cases of BC are 
diagnosed that will result in 1063 deaths (Mousavi et al., 
2007; Alizadeh et al., 2014). 
This study showed that the highest rates of BC 
incidence in women is in central provinces such as: Tehran, 
Isfahan, Yazd, Markazi and Fars provinces and the lowest 
incidences were for the provinces Sistan and Baluchestan, 
Khorasan, South Khorasan and Zanjan. These results are 
similar to previous reported results (Mahaki et al., 2011; 
Jafari-Koshki et al., 2014). Also due to Hadad khoshkar 
et al study in model without adjustment for risk factors, 
the highest incidence was for the provinces of Isfahan, 
Yazd and Tehran and the lowest incidence was for the 
provinces of Sistan and Baluchestan, Chaharmahal and 
Bakhtiari. With usage of model with adjustment for risk 
factors, the highest incidence was for the provinces of 
Khorasan, Lorestan and Hamedan and the lowest one was 
for Ardabil and Kohgiluyeh and BoyerAhmad provinces. 
A significant positive association between BC and 
economic-educational status was found (Mohagheghi 
et al., 2009; Khoshkar et al., 2015). Mohagheghi et al 
study in Tehran showed that socioeconomic status is an 
important variable in diagnosis of BC, avoiding problems 
related to cancer and raising awareness about the disorder 
(Mohaghegh et al., 2014). 
Some studies show uniformity in the incidence 
of this cancer. Babayi et al (2009) study in Ardebil 
represents a fairly steady trend in the incidence of 
this cancer over the years 2004-2006. Compared with 
sajjadi et al (2003) study in this province in years of 
1996-1999 that showed increased incidence of cancer, 
both studies are consistent with statistics of Cancer 
Registry Nouri nejad and Naghibi et al (2009,2013) 
study in Mazandaran province also showed an increasing 
trend in the incidence of BC among women in this 
province which is consistent with data from the Cancer 
Registry. Also a study in different provinces across the 
country showed that Isfahan has the lowest marriage 
rate and is located among the provinces which have high 
incidence of BC while Mazandaran with the highest rate of 
married people also is located among the risky provinces 
and Sistan and Baluchestan province with the lowest 
BMI is located among the provinces with low-risk BC 
incidence (Abbastabar et al., 2012b). Davari stated the 
following notes about risk factors of BC incidence 
in Yazd: “older ages, living in the city, early onset of 
menarche (under 14 year), late onset of menopause (over 
50 years) and family history of cancer are among the most 
important risk factors and a history of cancer in the uterus 
and ovaries, thoracic radiotherapy, other side BC and 
weight over 60 kg are among less important risk factors 
which has conformity with other countries statistically. 
But, in this study unlike other studies in the world, being 
single, the first pregnancy after age 30, having children and 
number of the children were not considered as risk factors 
for cancer and a history of benign BC was not among the 
risk factors unlike other studies(Abbastabar et al., 2012a).
According to a study conducted in south of Iran 
during the past 15 years, the lowest BC screening was in 
Zahedan (an eparchy in the South East of Iran) (Heidari 
et al., 2008), and the highest was in Tehran (Montazeri 
et al., 2008). Also the results of a study conducted in the 
city of Zabol in Sistan and Baluchestan province showed 
the low level of knowledge and practice about breast 
self-examination in people. The subjects were in a 
middle level of the subsets of health belief model. Also, the 
sensitivity perception, perceived risk, benefits and barriers, 
health motivation and self-confidence in BSE were higher in 
groups who knew and did this behavior. There was found a 
statistically significant relation between self-examination 
and positive family history of BC (Mahmood and 
Ramazani, 2011). Positive family history of BC is one of 
the main risk factors in Sabzevar city of North Khorasan 
Province. Due to the fact that the cancer incidence age in 
this city like other regions of country is a decade earlier 
than other countries, paying attention to early screening for 
women with positive family history has led to a reduction 
in the incidence in this province (Akbarzadeh et al., 2014). 
The results of Hot-Spots Analysis in this study showed 
that the distribution of BC in high-risk areas was more 
in central provinces of the country , Isfahan was known 
as BC Hot-Spot. According to the studies conducted in 
2005-2006, the BC incidence in Iranian women was 13.3% 
and 10% of all BC cases are related to Isfahan (Asadpour, 
2006). Mokarian et al (2011) study results showed that the 
incidence of cancer (4 per 1,000 People) in Isfahan 
province increased in recent years and gastrointestinal and 
BC Are pioneers in this area. There is a gender difference 
in the incidence of cancer and many people in middle 
age and with an average age of 56 years are affected. 
Early detection programs can lead to an increase in the 
incidence of BC.
Also another study in Dehaghan city of Isfahan showed 
that high prevalence of BC risk factors in women 20 to 
69 is related to people’s unhealthy lifestyles that includes 
irregular physical activity, exposure to smokers at home 
and a BMI of 30 or higher (Badrian et al., 2014). Also 
Key et al (2001) study showed that the consumption of 
foods high in fat and red meat increases the risk of BC. 
The results of studies on the consumption of foods such 
as vegetables and fruits show an inverse relationship with 
BC incidence. Some studies have shown conflicting 
results for example, Bushehr has the highest 
consumption of vegetables and Mazandaran has the 
highest marriage rate among the provinces but in 
both provinces, the incidence of BC was high. These 
contradictions can be attributed to the following reasons: 
1.BC is a multipurpose disease which develops from a 
combination of several risk factors. The value of a risk 
factor may be low in a province, but other factors value 
may be high in the province under study; 2. Data on the 
incidence of BC are collected from an example of each 
province population. Although the sample is randomly 
selected, it may not be representative of the total 
population and selection bias may have occurred 
(Abbastabar et al.).
The higher incidence in central provinces can be due 
to: air pollution, being more exposed to carcinogens in 
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urban areas or due to more cancer cases diagnosis in 
provinces, promoted western lifestyle, and increased 
pollution with development of economic situation. 
Development of the economic situation could lead to early 
detection of BC Patients (Abbastabar et al.). Also the risk 
of BC in working women is higher than housewives, and 
it could be due to socioeconomic status, exposure to stress 
or occupational carcinogens (Harirchi et al., 2012). Due 
to the decline in total fertility rate and life style changes, 
the number of BC new cases are expected to double in 
2030 (Mousavi et al., 2007). In Iran, no national screening 
program for BC is done and studies showed that women 
awareness of the warning and effective signs is very 
inadequate (Yavari and Pourhoseingholi, 2007; 
Montazeri et al., 2008). In addition, the health learning 
program for women in Iran in order to reduce the lack of 
women awareness about BC will be beneficial to control 
the cancer burden in the future (Sharifian et al., 2015).
 The higher incidence in central provinces can be due 
to more exposure to carcinogens in urban areas, Western 
lifestyle and high prevalence of other risk factors. So 
further epidemiological studies about the etiology and 
early detection of BC are essential.
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